Scientific Programme by Day Saturday, October 2, 2021
Total Page:16
File Type:pdf, Size:1020Kb
UEG Week Final Programme Saturday, October 2, 2021 Scientific Programme by Day Saturday, October 2, 2021 Vienna Live Session 18:00 – 18:45 TV Studio The UEG Week Premiere Chairs: Axel Dignass, DE Herbert Tilg, AT Helena Cortez-Pinto, PT 1 / 234 Audience Voting Case-Based Live Stream Question & Answer Recorded Session Debate Tandem Talk National Scholar Best Abstract Prize Rising Star UEG Week Final Programme Sunday, October 3, 2021 Scientific Programme by Day Live Session Sunday, October 3, 2021 09:00 – 10:00 Hall 1 Artificial intelligence: Impact for the lower GI tract Vienna Live Session Chairs: Daan W. Hommes, NL Eyal Klang, IL 08:00 – 09:00 TV Studio Opening Chairs: Herbert Tilg, AT Axel Dignass, DE 09:00 - 09:20 IP009 Helena Cortez-Pinto, PT Polyp detection and characterisation Cesare Hassan, IT 09:20 - 09:40 IP010 08:00 - 08:10 IP001 Role of AI in IBD endoscopy Words of welcome Raf Bisschops, BE Herbert Tilg, AT Axel Dignass, DE 09:40 - 10:00 IP011 IBD treatment algorithm driven by AI 08:10 - 08:25 IP002 Silvio Danese, IT NAFLD: From basic mechanisms to new therapies Elisabetta Bugianesi, IT Live Session 08:25 - 08:40 IP003 09:00 – 10:00 Hall 2 Endoscopic strategies targeting metabolic disorders Cutting edge approaches to the treatment of rectal Jacques Deviere, BE cancer 08:40 - 08:45 IP004 Chairs: Thomas Rösch, DE Antonino Spinelli, IT From T-cells to nutritional advice Nadine Cerf-Bensussan, FR 08:45 - 08:50 IP005 09:00 - 09:20 IP012 From T-cells to nutritional advice Imaging in early rectal cancer Raanan Shamir, IL Regina G.H. Beets-Tan, NL 08:50 - 09:00 09:20 - 09:40 IP013 Q&A Techniques beyond ESD: eFTR and EID Leon M.G. Moons, NL Live Session 09:40 - 10:00 IP014 09:00 – 10:00 TV Studio Advances in surgical excision for rectal lesions Mistakes in...I Dieter Hahnloser, CH Chairs: Marianna Arvanitakis, BE Live Session 09:00 - 09:10 IP006 09:00 – 10:00 Hall 3 Role of H. pylori in diseases and symptoms Mistakes in GI bleeding Chairs: Emad El-Omar, AU Bjorn Rembacken, UK Tamara Matysiak-Budnik, FR 09:10 - 09:20 IP007 Mistakes in capsule endoscopy Cristina Carretero, ES 09:00 - 09:20 IP015 The only good bug is a dead bug 09:20 - 09:30 IP008 Colm O'Morain, IE Mistakes in PPI treatment Arjan Bredenoord, NL 09:20 - 09:40 IP016 H. pylori and dyspepsia 09:30 - 10:00 Alexander Charles Ford, UK Panel discussion 09:40 - 10:00 IP017 H. pylori and malignancy Georgina L. Hold, AU 2 / 234 Audience Voting Case-Based Live Stream Question & Answer Recorded Session Debate Tandem Talk National Scholar Best Abstract Prize Rising Star UEG Week Final Programme Sunday, October 3, 2021 Live Abstract-based Session 09:24 - 09:36 OP008 09:00 – 10:00 Hall 4 ARTIFICIAL PANCREAS - BIHORMONAL CLOSED LOOP Towards a better understanding of dyspepsia and GLUCOSE CONTROL -VERSUS CURRENT CARE AFTER gastroparesis to improve therapeutic management TOTAL PANCREATECTOMY (APPEL5+): OUTPATIENT Chairs: Jan Tack, BE RANDOMIZED CONTROLLED CROSSOVER TRIAL Marten Alexander Lantinga, NL Charlotte van Veldhuisen, NL 09:36 - 09:48 OP009 TIMELINE OF DEVELOPMENT OF PANCREATIC CANCER 09:00 - 09:12 OP001 AND IMPLICATIONS FOR SUCCESSFUL EARLY DETECTION IN HIGH-RISK INDIVIDUALS MANAGEMENT OF FUNCTIONAL DYSPEPSIA IN EUROPE – EXPERT OPINION IN A CASE-BASED DELPHI APPROACH Kasper A. Overbeek, NL Jolien Schol, BE 09:48 - 10:00 OP010 09:12 - 09:24 OP002 AGE-DEPENDENT ASSOCIATION OF PANCREATIC FAMILY HISTORY WITH RECURRENT AND CHRONIC PANCREATITIS, DUODENAL DYSBIOSIS AND EFFICACY OF PROTON PUMP IDIOPATHIC ETIOLOGY AND RISK FACTORS: SECONDARY INHIBITORS IN FUNCTIONAL DYSPEPSIA: CAUSE OR ANALYSIS OF AN INTERNATIONAL COHORT OF 2,335 CONSEQUENCE? ACUTE PANCREATITIS PATIENTS Lucas Wauters, BE Márk Félix Juhász, HU 09:24 - 09:36 OP003 GASTROPARESIS IS ASSOCIATED WITH INCREASED Live Translational/Basic Science Session MORTALITY: RESULTS FROM A COHORT OF MORE THAN 13 000 PATIENTS-YEAR 09:00 – 10:00 Hall 6 Novel insights in onset and treatment of obesity Guillaume Gourcerol, FR Chairs: Ashley Blackshaw, UK 09:36 - 09:48 OP004 Jessica Rose Biesiekierski, AU SYMPTOMS AND DUODENAL MUCOSAL INTEGRITY ARE IMPROVED BY A DIETARY INTERVENTION IN FUNCTIONAL DYSPEPSIA 09:00 - 09:20 IP018 Karen Van den Houte, BE Microbiome and pathogenesis of obesity 09:48 - 10:00 OP005 Massimo Federici, IT ENDOSCOPIC PYLOROMYOTOMY (G-POEM) IMPROVES 09:20 - 09:40 IP019 SYMPTOMS IN PATIENTS WITH REFRACTORY Taste receptors and obesity: New target for treatment? GASTROPARESIS – A RANDOMIZED SHAM CONTROLLED Inge Depoortere, BE TRIAL Rastislav Hustak, CZ 09:40 - 10:00 IP020 Endoscopic treatment of obesity Roman Turro, ES Live Abstract-based Session 09:00 – 10:00 Hall 5 Challenges in clinical pancreatology Live Abstract-based Session Chairs: Juan Enrique Dominguez-Munoz, ES 09:00 – 10:00 Hall 7 Peter Hegyi, HU Advances in cirrhosis Chairs: Mark Thursz, UK Juan Carlos Garcia Pagan, ES 09:00 - 09:12 OP006 HISTOPATHOLOGICAL DIAGNOSIS OF SOLID PANCREATIC TUMORS FROM A PROSPECTIVE ENDOSCOPIC 09:00 - 09:12 OP011 ULTRASOUND-BASED REGISTRY: NOT EVERYTHING IS A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR PANCREATIC CANCER ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER Julio Iglesias-Garcia, ES FAILURE IN PATIENTS WITH CIRRHOSIS Lukas Hartl, AT 09:12 - 09:24 OP007 CHRONIC PANCREATITIS PROGNOSIS SCORE (COPPS): 09:12 - 09:24 OP012 RESULTS FROM AN INTERNATIONAL PROSPECTIVE INCREASED SURVIVAL IN PATIENTS WITH HEPATIC MULTICENTER VALIDATION STUDY ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN Georg Beyer, DE COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE Sean Walsh, UK 3 / 234 Audience Voting Case-Based Live Stream Question & Answer Recorded Session Debate Tandem Talk National Scholar Best Abstract Prize Rising Star UEG Week Final Programme Sunday, October 3, 2021 09:24 - 09:36 OP013 E-Poster Session VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION 09:00 – 19:00 Poster Exhibition WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED Oesophageal, gastric and duodenal disorders CHRONIC LIVER DISEASE Bernhard Scheiner, AT 09:00 - 09:00 P0001 09:36 - 09:48 OP014 THE FIRST REPORT ON THE NUCLEOTIDE ECTO-ENZYME INFLUENCE OF NON NEOPLASTIC PORTAL VEIN METABOLIC PATTERN IN THE RAT GASTRIC AND COLONIC THROMBOSIS ON SURVIVAL IN CIRRHOTIC PATIENTS WITH MUCOSA UNDER THE CONDITIONS OF HEPATOCELLUAR CARICINOMA CYCLOOXYGENASE-1/-2 BLOCKAGE WITH INDOMETHACIN Sarah Shalaby, IT Christina Nasadyuk, UA 09:48 - 10:00 OP015 09:00 - 09:00 P0003 THE ASSOCIATION OF LIVER STEATOSIS ASSESSED BY THE ROLE OF MAFB TRANSCRIPTION FACTOR IN HUMAN CONTROLLED ATTENUATED PARAMETER AND SEVERITY INTESTINAL METAPLASIA AND GASTRIC CANCER OF LIVER DISEASE WITH THE PRESENCE OF CIRRHOTIC BIOPSIES CARDIOMYOPATHY Rachel Gingold-Belfer, IL Marcel Razpotnik, AT 09:00 - 09:00 P0004 ZONULIN ASSAY IN CAPILLARY BLOOD ADSORBED ON Live Session DRIED BLOOD DEVICES 09:00 – 10:00 Hall 8 Nicola Volpi, IT East meets West 09:00 - 09:00 P0005 Chairs: Haruhiro Inoue, JP Helmut Messmann, DE HYDROGEN SULFIDE (H2S)-RELEASING AP-39 MODULATES GASTRIC MUCOSAL MITOCHONDRIAL ACTIVITY PREVENTING THE OXIDATIVE ISCHEMIA/REPERFUSION (I/R)-INDUCED GASTRIC MUCOSAL INJURY 09:00 - 09:05 IP021 Marcin Magierowski, PL Screening for oesophageal squamous cell cancer Pierre Henri Deprez, BE 09:00 - 09:00 P0006 EXPRESSION OF THERAPEUTIC TARGETS IN 09:05 - 09:10 IP022 GASTROESOPHAGEAL NEUROENDOCRINE CARCINOMA: Screening for oesophageal squamous cell cancer COMPARISON WITH COEXISTING ADENOCARCINOMA AND Sergey V. Kashin, RU SQUAMOUS CELL CARCINOMA COMPONENTS Satoshi Yamashita, JP 09:10 - 09:20 Q&A 09:00 - 09:00 P0007 ABERRANT MUC13 EXPRESSION AS PROGNOSTIC MARKER 09:20 - 09:25 IP023 FOR GASTRIC CANCER Gastric intestinal metaplasia and early gastric cancer Baptiste Oosterlinck, BE Mario Dinis-Ribeiro, PT 09:00 - 09:00 P0008 09:25 - 09:30 IP024 ELEVATED EPIDERMAL GROWTH FACTOR RECEPTOR Gastric intestinal metaplasia and early gastric cancer LEVELS IN BARRETT'S ESOPHAGUS Tsuneo Oyama, JP Tereza Deissová, CZ 09:30 - 09:40 09:00 - 09:00 P0009 Q&A HYPERPLASIC GASTRIC POLYPS : ABOUT 63 CASES 09:40 - 09:45 IP025 Walid Sellami, TN ESD for early gastric cancer Haruhiro Inoue, JP 09:00 - 09:00 P0010 METAGENOMIC AND METATRANSCRIPTOMIC ANALYSIS OF 09:45 - 09:50 IP026 THE STOMACH ANTRUM VS CORPUS BIOPSY MICROBIOTA ESD for early gastric cancer IN PATIENTS WITH GASTROINTESTINAL SYMPTOMS Helmut Messmann, DE Elena Kupriyanova, RU 09:50 - 10:00 09:00 - 09:00 P0011 Q&A CLOSTRIDIOIDES DIFFICILE INFECTION AFTER VARICEAL BLEEDING, A RISK TO BE CONSIDERED Bogdan Ungureanu, RO 4 / 234 Audience Voting Case-Based Live Stream Question & Answer Recorded Session Debate Tandem Talk National Scholar Best Abstract Prize Rising Star UEG Week Final Programme Sunday, October 3, 2021 09:00 - 09:00 P0012 09:00 - 09:00 P0022 SYSTEMATIC REVIEW WITH META-ANALYSIS: INFLUENCE ACUTE UPPER GASTROINTESTINAL BLEEDING IN OF INDIVIDUAL PROTON PUMP INHIBITORS ON CLINICAL PATIENTS USING ANTICOAGULANTS: DOES THE TIMING OF OUTCOMES IN PATIENTS RECEIVING CLOPIDOGREL ENDOSCOPY AFFECT OUTCOMES? FOLLOWING PERCUTANEOUS CORONARY INTERVENTION Tiago Lima Capela, PT Beom Jin Kim, KR 09:00 - 09:00 P0023 09:00 - 09:00 P0013 MODERN ANTICOAGULATION WITH FACTOR XA UPPER GASTROINTESTINAL BLEEDING IN VERY OLD INHIBITORS IN ONCOLOGY: IS THE GASTROINTESTINAL PATIENTS. RISK FACTORS FOR IN-HOSPITAL AND DELAYED BLEEDING RATE (ALSO) DECISIVE? MORTALITY Martin Raithel, DE Rita Jiménez-Rosales, ES 09:00 - 09:00 P0024 09:00 - 09:00 P0014 OVERLAPPING OF IRRITABLE BOWEL SYNDROME AND USE OF INTRAVENOUS IRON REDUCES MORTALITY, UNINVESTIGATED DYSPEPSIA IN THE ADMINISTRATIVE